Daniel J. Weiss, MD, PhD
Vice – Chair (June 2019-2020)
University of Vermont
Burlington, VT, United States

[1] Dominici M, Nichols K, Srivastava A, Weiss DJ, Eldridge P, Cuende N, Deans RJ, Rasko JE, Levine AD, Turner L, Griffin DL, O’Donnell L, Forte M, Mason C, Wagena E, Janssen W, Nordon R, Wall D, Ho HN, Ruiz MA, Wilton S, Horwitz EM, Gunter KC. 2013–2015 ISCT Presidential Task Force on Unproven Cellular Therapy. Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective.  Cytotherapy 2015;17(12):1663-6. https://doi.org/10.1016/j.jcyt.2015.10.007

[2] Ikonomou L, Freishtat RJ, Wagner DE, Panoskaltsis-Mortari A, Weiss DJ. The Global Emergence of Unregulated Stem Cell Treatments for Respiratory Diseases. Professional Societies Need to Act.  Ann Am Thorac Soc. 2016 Aug;13(8):1205-7. https://doi.org/10.1513/AnnalsATS.201604-277ED

[3] Weiss DJ, Rasko JE, Cuende N, Ruiz MA, Ho HN, Nordon R, Wilton S, Dominici M, Srivastava A.  Part 2: Making the “unproven” “proven”.  Cytotherapy 2016 Jan;18(1):120-3. https://doi.org/10.1016/j.jcyt.2015.11.005

[4] Srivastava A, Mason C, Wagena E, Cuende N, Weiss DJ, Horwitz EM, Dominici M. Part 1: Defining unproven cellular therapies. Cytotherapy 2016 Jan;18(1):117-9. https://doi.org/10.1016/j.jcyt.2015.11.004

[5] Ikonomou L, Panoskaltsis-Mortari A, Wagner DE, Freishtat RJ, Weiss DJ; American Thoracic Society Respiratory Cell and Molecular Biology Assembly Stem Cell Working Group. Unproven Stem Cell Treatments for Lung Disease-An Emerging Public Health Problem. Am J Respir Crit Care Med 2017;195(7):P13-P14. doi: 10.1164/rccm.1957P13. No abstract available. PMID: 28362195.

[6] Wagner DE, Turner L, Panoskaltsis-Mortari A, Weiss DJ, Ikonomou L. Co-opting of ClinicalTrials.gov by patient-funded studies. Lancet Respir Med. 2018; pii: S2213-2600(18)30242-X. doi: 10.1016/S2213-2600(18)30242-X

[7] Weiss DJ, Turner L, Levine AD, Ikonomou L.  Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions. Cytotherapy 2018;20(2):165-168. doi: 10.1016/j.jcyt.2017.10.002. Epub 2017 Nov 24.  PMID:29239793.

[8] Ikonomou L, Wagner DE, Turner L, Weiss DJ. Translating Basic Research into Safe and Effective Cell-based Treatments for Respiratory Diseases.  Ann Am Thorac Soc. 2019;16(6):657-668. doi: 10.1513/AnnalsATS.201812-890CME.  PMID: 30917290.

[9] Ikonomou L and Weiss DJ.  Turning the tide on unproven cell-based interventions. CHEST, in press 2019